How might stress contribute to increased risk for schizophrenia in children with chromosome 22q11.2 deletion syndrome?

Journal of Neurodevelopmental Disorders

Volumn 3, Issue 1, 2011, Pages 68-75

  Beaton, Elliott A ^a   Simon, Tony J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Allostatic load; Children; Cortisol; Developmental disorder; Genotype; Hypothalamic pituitary adrenal axis (HPA axis); Schizophrenia; Socioemotional development; Stress diathesis; Velo cardio facial syndrome (VCFS)

Indexed keywords

EID: 79952696627     PISSN: 18661947     EISSN: 18661955     Source Type: Journal    
DOI: 10.1007/s11689-010-9069-9     Document Type: Article

References (118)

1. Alfarez DN, Joëls M, Krugers HJ. Chronic unpredictable stress impairs long-term potentiation in rat hippocampal CA1 area and dentate gyrus in vitro. Eur J Neurosci. 2003; 17: 1928-34.
2. Arinami T. Analyses of the associations between the genes of 22q11 deletion syndrome and schizophrenia. J Hum Genet. 2006; 51: 1037-45.
3. Arnold PD, Siegel-Bartelt J, Cytrynbaum C, Teshima I, Schachar R. Velo-cardio-facial syndrome: implications of microdeletion 22q11 for schizophrenia and mood disorders. Am J Med Genet. 2001; 105: 354-62.
4. Arnsten AFT. Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci. 2009; 10: 410-22.
5. Aron DC, Findling JW, Tyrrell JB. Hypothalamus and pituitary gland. In: Greenspan FS, Gardner DG, editors. Basic and clinical endocrinology. 7th ed. New York: Lange Medical Books/McGraw Hill; 2004. p. 106-75.
6. Baker KD, Skuse DH. Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group. Br J Psychiatry. 2005; 186: 115-20.
7. Bassett AS, Chow EW. 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry. 1999; 46: 882-91.
8. Bassett AS, Chow EW, AbdelMalik P, Gheorghiu M, Husted J, Weksberg R. The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry. 2003; 160: 1580-6.
9. Bassett AS, Chow EWC, Husted J, Weksberg R, Caluseriu O, Webb GD, et al. Clinical features of 78 adults with 22q11 deletion syndrome. Am J Med Genet A. 2005; 138A: 307-13.
10. Bassett AS, Caluseriu O, Weksberg R, Young DA, Chow EWC. Catechol-O-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome. Biol Psychiatry. 2007; 61: 1135-40.
11. Bearden CE, Woodin MF, Wang PP, Moss E, McDonald-McGinn D, Zackai E, et al. The neurocognitive phenotype of the 22q11. 2 deletion syndrome: selective deficit in visual-spatial memory. J Clin Exp Neuropsychol. 2001; 23: 447-64.
12. Botto LD, May K, Fernhoff PM, Correa A, Coleman K, Rasmussen SA, et al. A population-based study of the 22q11. 2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics. 2003; 112: 101-7.
13. Bremner JD. Neuroimaging in posttraumatic stress disorder and other stress-related disorders. Neuroimaging Clin N Am. 2007; 17: 523-38. ix.
14. Bremner JD, Randall P, Vermetten E, Staib L, Bronen RA, Mazure C, et al. Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse-a preliminary report. Biol Psychiatry. 1997; 41: 23-32.
15. Briegel W, Schneider M, Schwab KO. 22q11. 2 deletion syndrome: behaviour problems of infants and parental stress. Child Care Health Dev. 2007; 33(3): 319-24.
16. Burkhardt S. Non-verbal learning disabilities. San Diego: Emerald Group Publishing Limited; 2005.
17. Carlsson A. The current state of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 1988; 1: 179-86.
18. Carotti A, Digilio MC, Piacentini G, Saffirio C, Donato RMD, Marino B. Cardiac defects and results of cardiac surgery in 22q11. 2 deletion syndrome. Dev Disabil Res Rev. 2008; 14: 35-42.
19. Caserta MT, O'Connor TG, Wyman PA, Wang H, Moynihan J, Cross W, et al. The associations between psychosocial stress and the frequency of illness, and innate and adaptive immune function in children. Brain Behav Immun. 2008; 22: 933-40.
20. Cooper-Brown L, Copeland S, Dailey S, Downey D, Petersen MC, Stimson C, et al. Feeding and swallowing dysfunction in genetic syndromes. Dev Disabil Res Rev. 2008; 14: 147-57.
21. Craddock N, Owen MJ, O'Donovan MC. The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons. Mol Psychiatry. 2006; 11: 446-58.
22. Craenenbroeck KV, Bosscher KD, Berghe WV, Vanhoenacker P, Haegeman G. Role of glucocorticoids in dopamine-related neuropsychiatric disorders. Mol Cell Endocrinol. 2005; 245: 10-22.
23. Davidson JRT. Anxiety and affective style: role of prefrontal cortex and amygdala. Biol Psychiatry. 2002; 51: 68-80.
24. de Pablos RM, Villaran RF, Arguelles S, Herrera AJ, Venero JL, Ayala A, et al. Stress increases vulnerability to inflammation in the rat prefrontal cortex. J Neurosci. 2006; 26: 5709-19.
25. Debbané M, Schaer M, Farhoumand R, Glaser B, Eliez S. Hippocampal volume reduction in 22q11. 2 deletion syndrome. Neuropsychologia. 2006; 44: 2360-5.
26. DeBoer T, Wu Z, Lee A, Simon T. Hippocampal volume reduction in children with chromosome 22q11. 2 deletion syndrome is associated with cognitive impairment. Behav Brain Funct. 2007; 3: 54.
27. deCatanzaro DA. Motivation and emotion: evolutionary, physiological, developmental, and social perspectives. Upper Saddle River: Prentice Hall; 1999.
28. Diamond DM, Rose GM. Stress impairs LTP and hippocampal-dependent memorya. Ann NY Acad Sci. 1994; 746: 411-4.
29. Drabant EM, Hariri AR, Meyer-Lindenberg A, Munoz KE, Mattay VS, Kolachana BS, et al. Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Arch Gen Psychiatry. 2006; 63: 1396-406.
30. Driscoll DA, Salvin J, Sellinger B, Budarf ML, McDonald-McGinn DM, Zackai EH, et al. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. J Med Genet. 1993; 30: 813-7.
31. Dufour F, Schaer M, Debbané M, Farhoumand R, Glaser B, Eliez S. Cingulate gyral reductions are related to low executive functioning and psychotic symptoms in 22q11. 2 deletion syndrome. Neuropsychologia. 2008; 46: 2986-92.
32. Dunham I, Collins J, Wadley R, Scambler P. Possible role for COMT in psychosis associated with velo-cardio-facial syndrome. Lancet. 1992; 340: 1361-2.
33. Eliez S, Schmitt JE, White CD, Reiss AL. Children and adolescents with velocardiofacial syndrome: a volumetric study. Am J Psychiatry. 2000; 157: 409-15.
34. Elzinga BM, Roelofs K, Tollenaar MS, Bakvis P, van Pelt J, Spinhoven P. Diminished cortisol responses to psychosocial stress associated with lifetime adverse events: a study among healthy young subjects. Psychoneuroendocrinology. 2008; 33: 227-37.
35. Fan J-B, Zhang C-S, Gu N-F, Li X-W, Sun W-W, Wang H-Y, et al. Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biol Psychiatry. 2005; 57: 139-44.
36. Fox NA, Calkins SD, Schmidt L, Rubin KH, Coplan RJ. The role of frontal activation in the regulation and dysregulation of social behavior during the preschool years. Dev Psychopathol. 1996; 8: 89-102.
37. Freeman D, Fowler D. Routes to psychotic symptoms: trauma, anxiety and psychosis-like experiences. Psychiatry Res. 2009; 169: 107-12.
38. Goodship J, Cross I, Scambler P, Burn J. Monozygotic twins with chromosome 22q11 deletion and discordant phenotype. J Med Genet. 1995; 32: 746-8.
39. Goodyer IM, Herbert J, Altham PM. Adrenal steroid secretion and major depression in 8- to 16-year-olds. III. Influence of cortisol/DHEA ratio at presentation on subsequent rates of disappointing life events and persistent major depression.Psychol Med. 1998; 28: 265-73.
40. Gothelf D, Eliez S, Thompson T, Hinard C, Penniman L, Feinstein C, et al. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11. 2 deletion syndrome. Nat Neurosci. 2005; 8: 1500-2.
41. Gothelf D, Feinstein C, Thompson T, Gu E, Penniman L, van Stone E, et al. Risk factors for the emergence of psychotic disorders in adolescents with 22q11. 2 deletion syndrome. Am J Psychiatry. 2007; 164: 663-9.
42. Gothelf D, Schaer M, Eliez S. Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome. Dev DisabilRes Rev. 2008; 14: 59-68.
43. Gothelf D, Hoeft F, Ueno T, Sugiura L, Lee AD, Thompson P, et al. Developmental changes in multivariate neuroanatomical patterns that predict risk for psychosis in 22q11. 2 deletion syndrome. J Psychiatr Res 2010;(in press).
44. Heim C, Nemeroff CB. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry. 2001; 49: 1023-39.
45. Hercher L, Bruenner G. Living with a child at risk for psychotic illness: the experience of parents coping with 22q11 deletion syndrome: an exploratory study. Am J Med Genet A. 2008; 146A: 1552-4825.
46. Hillebrand G, Siebert R, Simeoni E, Santer R. DiGeorge syndrome with discordant phenotype in monozygotic twins. J Med Genet. 2000; 37: e23.
47. Jabbi M, Korf J, Kema IP, Hartman C, van der Pompe G, Minderaa RB, et al. Convergent genetic modulation of the endocrine stress response involves polymorphic variations of 5-HTT, COMT and MAOA. Mol Psychiatry. 2007; 12: 483-90.
48. Johnson EO, Kamilaris TC, Chrousos GP, Gold PW. Mechanisms of stress: a dynamic overview of hormonal and behavioral homeostasis. Neurosci Biobehav Rev. 1992; 16: 115-30.
49. Juranek J, Filipek PA, Berenji GR, Modahl C, Osann K, Spence MA. Association between amygdala volume and anxiety level: magnetic resonance imaging (MRI) study in autistic children. J Child Neurol. 2006; 21: 1051-8.
50. Kalimi M, Shafa Y, Loria R, Padgett D, Regelson W. Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA). Mol Cell Biochem. 1994; 131: 99-104.
51. Karayiorgou M, Simon TJ, Gogos JA. 22q11. 2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat Rev Neurosci. 2010; 11: 402-16.
52. Kates WR, Burnette CP, Jabs EW, Rutberg J, Murphy AM, Grados M, et al. Regional cortical white matter reductions in velocardiofacial syndrome: a volumetric MRI analysis. Biol Psychiatry. 2001; 49: 677-84.
53. Kates WR, Miller AM, Abdulsabur N, Antshel KM, Conchelos J, Fremont W, et al. Temporal lobe anatomy and psychiatric symptoms in velocardiofacial syndrome (22q11. 2 deletion syndrome). J Am Acad Child Adolesc Psychiatry. 2006; 45: 587-95.
54. Kates WR, Krauss BR, Abdulsabur N, Colgan D, Antshel KM, Higgins AM, et al. The neural correlates of non-spatial working memory in velocardiofacial syndrome (22q11. 2 deletion syndrome). Neuropsychologia. 2007; 45: 2863-73.
55. Kendall PC. Treating anxiety disorders in children: results of a randomized clinical trial. J Consult Clin Psychol. 1994; 62: 100-10.
56. Kinsbourne M. Asymmetrical function of the brain. New York: Cambridge University Press; 1978.
57. Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11. 2 deletion syndromes. Lancet. 2007; 370: 1443-52.
58. Lange C, Irle E. Enlarged amygdala volume and reduced hippocampal volume in young women with major depression. Psychol Med. 2004; 34: 1059-64.
59. Liu H, Heath SC, Sobin C, Roos JL, Galke BL, Blundell ML, et al. Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc Natl Acad Sci. 2002; 99: 3717-22.
60. Mahle WT, Crisalli J, Coleman K, Campbell RM, Tam VKH, Vincent RN, et al. Deletion of chromosome 22q11. 2 and outcome in patients with pulmonary atresia and ventricular septal defect. Ann Thorac Surg. 2003; 76: 567-71.
61. Marco EM, Macrì S, Laviola G. Critical age windows for neurodevelopmental psychiatric disorders: evidence from animal models. Neurotox Res 2010;(in press).
62. Margariños AM, McEwan BS, Flügge G, Fuchs E. Chronic psychosocial stress causes apical dendritic atrophy of CA3 pryamidal neurons in subordinate tress shrews. J Neurosci. 1996; 16: 3534-40.
63. Maroun M, Richter-Levin G. Exposure to acute stress blocks the induction of long-term potentiation of the amygdala-prefrontal cortex pathway in vivo. J Neurosci. 2003; 23: 4406-9.
64. Mathew SJ, Price RB, Charney DS. Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics. Am J Med Genet C Semin Med Genet. 2008; 148C: 89-98.
65. McEwen BS. Stress and the aging hippocampus. Front Neuroendocrinol. 1999; 20: 49-70.
66. McEwen BS. Early life influences on life-long patterns of behavior and health. Ment Retard Dev Disabil Res Rev. 2003; 9: 149-54.
67. McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007; 87: 873-904.
68. McLean-Tooke A, Spickett GP, Gennery AR. Immunodeficiency and autoimmunity in 22q11. 2 deletion syndrome. Scand J Immunol. 2007; 66: 1-7.
69. Michaelovsky E, Gothelf D, Korostishevsky M, Frisch A, Burg M, Carmel M, et al. Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11. 2DS. Int J Neuropsychopharmacol. 2008; 11: 351-63.
70. Mizoguchi K, Kunishita T, Chui D, Tabira T. Stress induces neuronal death in the hippocampus of castrated rats. Neurosci Lett. 1992; 138: 157-60.
71. Mizoguchi K, Ishige A, Takeda S, Aburada M, Tabira T. Endogenous glucocorticoids are essential for maintaining prefrontal cortical cognitive function. J Neurosci. 2004; 24: 5492-9.
72. Morgan C, Fisher H. Environment and schizophrenia: environmental factors in schizophrenia: childhood trauma-a critical review. Schizophr Bull. 2007; 33: 3-10.
73. Murphy KC. Schizophrenia and velo-cardio-facial syndrome. Lancet. 2002; 359: 426-30.
74. Murphy KC, Scambler PJ, editors. Velo-cardio-facial syndrome: a model for understanding microdeletion disorders. Cambridge: Cambridge University Press; 2005.
75. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry. 1999; 56: 940-5.
76. Plotsky PM, Meaney MJ. Early postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Mol Brain Res. 1993; 18: 195-200.
77. Read J, Os J, Morrison AP, Ross CA. Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications. Acta Psychiatr Scand. 2005; 112: 330-50.
78. Richert KA, Carrion VG, Karchemskiy A, Reiss AL. Regional differences of the prefrontal cortex in pediatric PTSD: an MRI study. Depress Anxiety. 2006; 23: 17-25.
79. Roussos P, Giakoumaki SG, Bitsios P. A risk PRODH haplotype affects sensorimotor gating, memory, schizotypy, and anxiety in healthy male subjects. Biol Psychiatry. 2009; 65: 1063-70.
80. Rudolph AM. Congenital cardiovascular malformations and the fetal circulation. Arch Dis Child Fetal and Neonatal Ed. 2010; 95: F132-6.
81. Saetre P, Emilsson L, Axelsson E, Kreuger J, Lindholm E, Jazin E. Inflammation-related genes up-regulated in schizophrenia brains. BMC Psychiatry. 2007; 7: 46.
82. Sapolsky RM. A mechanism for glucocorticoid toxicity in the hippocampus: increased neuronal vulnerability to metabolic insults. J Neurosci. 1985; 5: 1228-32.
83. Sapolsky R. Glucocorticoid toxicity in the hippocampus: synergy with an excitotoxin. Neuroendocrinology. 1986; 43: 440-6.
84. Sapolsky RM. Stress and plasticity in the limbic system. Neurochem Res. 2003; 28: 1735-42.
85. Sapolsky RM, Krey LC, McEwen BS. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J Neurosci. 1985; 5: 1222-7.
86. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev. 1986; 7: 284-301.
87. Sapolsky RM, Uno H, Rebert CS, Finch CE. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci. 1990; 10: 2897-902.
88. Scambler PJ. The 22q11 deletion syndromes. Hum Mol Genet. 2000; 9: 2421-6.
89. Schmidt LA, Segalowitz SJ (eds.) (2007) Developmental psychophysiology: Theory, Systems, and Methods. New York, NY: Cambridge University Press.
90. Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, Weizman A, et al. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet. 2002; 71: 1296-302.
91. Shprintzen RJ. Velo-cardio-facial syndrome: 30years of study. Dev Disabil Res Rev. 2008; 14: 3-10.
92. Sigurdsson T, Stark KL, Karayiorgou M, Gogos JA, Gordon JA. Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature. 2010; 464: 763-7.
93. Simon TJ, Bearden CE, McDonald-McGinn DM, Zackai E. Visuospatial and numerical cognitive deficits in children with chromosome 22q11. 2 deletion syndrome. Cortex. 2005a; 41: 145-55.
94. Simon TJ, Ding L, Bish JP, McDonald-McGinn DM, Zackai EH, Gee J. Volumetric, connective, and morphologic changes in the brains of children with chromosome 22q11. 2 deletion syndrome: an integrative study. Neuroimage. 2005b; 25: 169-80.
95. Smolka MN, Schumann G, Wrase J, Grusser SM, Flor H, Mann K, et al. Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci. 2005; 25: 836-42.
96. Sowell ER, Thompson PM, Leonard CM, Welcome SE, Kan E, Toga AW. Longitudinal mapping of cortical thickness and brain growth in normal children. J Neurosci. 2004; 24: 8223-31.
97. Spinelli S, Chefer S, Suomi SJ, Higley JD, Barr CS, Stein E. Early-life stress induces long-term morphologic changes in primate brain. Arch Gen Psychiatry. 2009; 66: 658-65.
98. Sprong M, Becker HE, Schothorst PF, Swaab H, Ziermans TB, Dingemans PM, et al. Pathways to psychosis: a comparison of the pervasive developmental disorder subtype multiple complex developmental disorder and the "At Risk Mental State". Schizophr Res. 2008; 99: 38-47.
99. Stein MB, Fallin MD, Schork NJ, Gelernter J. COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology. 2005; 30: 2092-102.
100. Stoddard J, Niendam T, Hendren R, Carter C, Simon TJ. Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11. 2 deletion syndrome. Schizophr Res. 2010; 118(1-3): 118-21.
101. Swillen A, Devriendt K, Legius E, Prinzie P, Vogels A, Ghesquiere P, et al. The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence. Genet Couns. 1999; 10: 79-88.
102. Swillen A, Devriendt K, Ghesquiere P, Fryns JP. Children with a 22q11 deletion versus children with a speech-language impairment and learning disability: behavior during primary school age. Genet Couns. 2001; 12: 309-17.
103. Tottenham N, Hare TA, Quinn BT, McCarry TW, Nurse M, Gilhooly T, et al. Prolonged institutional rearing is associated with atypically large amygdala volume and difficulties in emotion regulation. Dev Sci. 2010; 13: 46-61.
104. Toulopooulou T, Grech A, Morris RG, Schulze K, McDonald C, Chapple B, et al. The relationship between volumetric brain changes and cognitive function: a family study on schizophrenia. Biol Psychiatry. 2004; 56: 447-53.
105. Turner-Cobb JM. Psychosocial and stress hormone correlates in early life: a key to HPA-axis disregulation and normalization. Stress. 2005; 8: 47-57.
106. Vaillancourt T, Duku E, Decatanzaro D, Macmillan H, Muir C, Schmidt LA. Variation in hypothalamic-pituitary-adrenal axis activity among bullied and non-bullied children. Aggress Behav. 2008; 34: 294-305.
107. van Amelsvoort T, Daly E, Robertson D, Suckling J, Ng V, Critchley H, et al. Structural brain abnormalities associated with the deletion at chromosome 22q11. Br J Psychiatry. 2001; 178: 412-9.
108. Val158Met polymorphism moderates sensitivity to stress in psychosis: an experience-sampling study. Am J Med Genet B Neuropsychiatr Genet. 2008; 147B: 10-7.
109. Velakoulis D, Pantelis C. What have we learned from functional imaging studies in schizophrenia? The role of frontal, striatal and temporal areas. Aust NZ J Psychiatry. 1996; 30: 195-209.
110. Walker E, Mittal V, Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psychol. 2008; 4: 189-216.
111. Webster Marketon JI, Glaser R. Stress hormones and immune function. Cell Immunol. 2008; 252: 16-26.
112. Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, et al. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry. 2001; 50: 825-44.
113. Williams HJ, Owen MJ, O'Donovan MC. Is COMT a susceptibility gene for schizophrenia? Schizophr Bull. 2007; 33: 635-41.
114. Woodin MF, Wang PP, Aleman D, McDonald-McGinn DM, Zackai EH, Moss EM. Neuropsychological profile of children and adolescents with the 22q11. 2 microdeletion. Genet Med. 2001; 3: 34-9.
115. Woolley CS, Gould E, McEwen BS. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 1990; 531: 225-31.
116. Wyman PA, Moyniham J, Eberly S, Cox C, Cross W, Jin X, et al. Association of family stress with natural killer cell activity and the frequency of illnesses in children. Arch Pediatr Adolesc Med. 2007; 161: 228-34.
117. Yamagishi H, Ishii C, Maeda J, Kojima Y, Matsuoka R, Kimura M, et al. Phenotypic discordance in monozygotic twins with 22q11. 2 deletion. Am J Med Genet. 1998; 78: 319-21.
118. Yang RJ, Mozhui K, Karlsson RM, Cameron HA, Williams RW, Holmes A. Variation in mouse basolateral amygdala volume is associated with differences in stress reactivity and fear learning. Neuropsychopharmacology. 2008; 33: 2595-604.